People · Operator
Named in public records as an officer, director or promoter · active 2009–2017 · Other Health Care, Other Technology, Biotechnology, Healthtech, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Proteus Biomedical Inc | — | Other Health Care | Series D+ | $162.4M | $2.7B | 2009 |
| Pixeloptics Inc | — | Other Technology | Series B | $65.1M | $106.6M | 2011 |
| Neovista Inc | — | Other Health Care | Series B | $63.3M | $114.9M | 2009 |
| Aquesys Inc | — | Biotechnology | Series B | $49.5M | $1.2B | 2014 |
| Lucent Health Solutions, Inc. | — | Healthtech | Series B | $22.5M | $24.8M | 2014 |
| Transport Pharmaceuticals Inc | — | Pharmaceuticals | Pre-Seed | $1.7M | $9.5M | 2009 |
| Cellutions Inc | — | Biotechnology | Pre-Seed | $1.0M | $55.2M | 2009 |
Ryan Schwarz at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ryan Schwarz on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.